ReposiTrak furnishes Q3 2025 earnings release and call transcript

Rhea-AI Filing Summary

ReposiTrak, Inc. reported that it has released its financial results for the fiscal quarter ended September 30, 2025. The company issued a press release and held an earnings call on November 13, 2025 to discuss these results. The press release and the full earnings call transcript are provided as exhibits to this report, giving investors access to detailed quarterly performance information and management’s commentary. The common stock of ReposiTrak continues to trade on the New York Stock Exchange under the symbol TRAK.

8-K Event Classification

3 items: 2.02, 7.01, 9.01

3 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

false 0000050471 0000050471 2025-11-17 2025-11-17

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  November 17, 2025

REPOSITRAK, INC.

(Exact name of Registrant as specified in its Charter)

Nevada	001-34941	37-1454128
(State or other jurisdiction of incorporation)	(Commission File No.)	(IRS Employer Identification No.)

5282 South Commerce Drive, Suite D292, Murray, Utah 84107

(Address of principal executive offices)

(435) 645-2000

(Registrant’s Telephone Number)

Not Applicable

(Former name or address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of exchange on which registered
Common stock, par value $0.01 per share	TRAK	New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2)

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ 

Item 2.02 Results of Operations and Financial Condition.

On November 13, 2025, ReposiTrak, Inc. (the “Company”) issued a press release and hosted an earnings call to announce the Company’s financial results for the fiscal quarter ended September 30, 2025. A copy of the press release and the earnings call transcript are attached hereto as Exhibit 99.1 and 99.2, respectively.

Item 7.01 Regulation FD Disclosure.

See Item 2.02.

In accordance with General Instruction B.2 for Form 8-K, the information in this Form 8-K, including Exhibits 99.1 and 99.2, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit Number		Description
99.1		Press Release, dated November 13, 2025
99.2		Earnings Call Transcript
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	REPOSITRAK, INC.
Date: November 17, 2025	/s/ John Merrill
	John Merrill
	Chief Financial Officer

FAQ

What did ReposiTrak, Inc. (TRAK) announce in this 8-K filing?

ReposiTrak, Inc. announced that it issued a press release and hosted an earnings call on November 13, 2025 to discuss its financial results for the fiscal quarter ended September 30, 2025.

Which fiscal period do the disclosed ReposiTrak (TRAK) results cover?

The disclosed results cover ReposiTrak’s fiscal quarter ended September 30, 2025.

Where can investors find the detailed ReposiTrak (TRAK) quarterly results?

Detailed information is included in Exhibit 99.1 (press release dated November 13, 2025) and Exhibit 99.2 (earnings call transcript) attached to this report.

Does this ReposiTrak 8-K filing treat the earnings information as filed or furnished?

The information in this report, including Exhibits 99.1 and 99.2, is stated to not be deemed “filed” for purposes of Section 18 of the Exchange Act, but rather furnished, unless specifically incorporated by reference elsewhere.

What stock exchange does ReposiTrak (TRAK) trade on and under what ticker?

ReposiTrak’s common stock trades on the New York Stock Exchange under the ticker symbol TRAK.

Who signed the ReposiTrak (TRAK) 8-K report?

The report was signed on behalf of ReposiTrak, Inc. by John Merrill, the company’s Chief Financial Officer.